Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse

Abstract Immunotherapy is a promising approach for specific targeting of cancer cells. Leukemia inhibitory factor (LIF) regulates several features of cancers and cancer stem cells (CSCs) through binding to LIF receptor (LIFR). In this study, we investigated the consensus of LIF and LIFR immunization...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Ghanei, Nahid Mehri, Abbas Jamshidizad, Morteza Daliri Joupari, Mehdi Shamsara
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
R
Q
Online Access:https://doaj.org/article/758b9fb6182845adaa8c87589de7b179
Tags: Add Tag
No Tags, Be the first to tag this record!